These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, Nerlich M, Schlitt HJ, Kellum JA, Bein T. PLoS One; 2015 Apr; 10(3):e0120863. PubMed ID: 25798585 [Abstract] [Full Text] [Related]
25. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes. Lobato GR, Lobato MR, Thomé FS, Veronese FV. Braz J Med Biol Res; 2017 Mar 30; 50(5):e6106. PubMed ID: 28380198 [Abstract] [Full Text] [Related]
26. Cytokine elevation and transaminitis after laparoscopic donor nephrectomy. Yap S, Park SW, Egan B, Lee HT. Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1104-11. PubMed ID: 22262478 [Abstract] [Full Text] [Related]
27. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury. Westhoff JH, Seibert FS, Waldherr S, Bauer F, Tönshoff B, Fichtner A, Westhoff TH. Eur J Pediatr; 2017 Jun 01; 176(6):745-755. PubMed ID: 28409285 [Abstract] [Full Text] [Related]
28. Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides. Chui H, Caldwell J, Yordanova M, Cockovski V, Fredric D, Harel-Sterling M, Haasz M, Al-Ismaili Z, Pizzi M, Ma Q, Devarajan P, Goldstein SL, Zappitelli M. Biomark Med; 2020 Jul 01; 14(10):879-894. PubMed ID: 32808826 [Abstract] [Full Text] [Related]
29. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers. Dusse F, Edayadiyil-Dudásova M, Thielmann M, Wendt D, Kahlert P, Demircioglu E, Jakob H, Schaefer ST, Pilarczyk K. BMC Anesthesiol; 2016 Sep 08; 16():76. PubMed ID: 27609347 [Abstract] [Full Text] [Related]
30. Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia. Rumpel J, Spray BJ, Chock VY, Kirkley MJ, Slagle CL, Frymoyer A, Cho SH, Gist KM, Blaszak R, Poindexter B, Courtney SE. J Pediatr; 2022 Feb 08; 241():133-140.e3. PubMed ID: 34547334 [Abstract] [Full Text] [Related]
31. Prospective assessment of urinary neutrophil gelatinase-associated lipoprotein in living kidney donors: toward understanding differences between chronic kidney diseases of surgical and medical origin. Yoon YE, Lee HH, Na JC, Han WK. BJU Int; 2019 May 08; 123(5):869-876. PubMed ID: 30347133 [Abstract] [Full Text] [Related]
32. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. Morrissey JJ, London AN, Lambert MC, Kharasch ED. Am J Nephrol; 2011 May 08; 34(5):391-8. PubMed ID: 21912102 [Abstract] [Full Text] [Related]
33. Urinary Biomarkers for Cell Cycle Arrest TIMP-2 and IGFBP7 for Prediction of Graft Function Recovery after Kidney Transplantation. Gäckler A, Ertasoglu O, Rohn H, Friebus-Kardash J, Ickerott PC, Witzke O, Kribben A, Vogt B, Dahdal S, Arampatzis S, Eisenberger U. Int J Mol Sci; 2024 Apr 10; 25(8):. PubMed ID: 38673754 [Abstract] [Full Text] [Related]
34. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. Wang Y, Zou Z, Jin J, Teng J, Xu J, Shen B, Jiang W, Zhuang Y, Liu L, Luo Z, Wang C, Ding X. BMC Nephrol; 2017 May 30; 18(1):177. PubMed ID: 28558754 [Abstract] [Full Text] [Related]
35. Urinary Tissue Inhibitor of Metalloproteinase and Insulin-like Growth Factor-7 as Early Biomarkers of Delayed Graft Function After Kidney Transplantation. Yang J, Lim SY, Kim MG, Jung CW, Cho WY, Jo SK. Transplant Proc; 2017 Nov 30; 49(9):2050-2054. PubMed ID: 29149959 [Abstract] [Full Text] [Related]
36. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, de Jong PE, Gansevoort RT. Am J Kidney Dis; 2010 Nov 30; 56(5):883-95. PubMed ID: 20888104 [Abstract] [Full Text] [Related]
37. Urinary Biomarkers KIM-1 and NGAL for Detection of Chronic Kidney Disease of Uncertain Etiology (CKDu) among Agricultural Communities in Sri Lanka. De Silva PM, Mohammed Abdul KS, Eakanayake EM, Jayasinghe SS, Jayasumana C, Asanthi HB, Perera HS, Chaminda GG, Chandana EP, Siribaddana SH. PLoS Negl Trop Dis; 2016 Sep 30; 10(9):e0004979. PubMed ID: 27643785 [Abstract] [Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA, Köttgen A, Coresh J, Astor BC. Am J Kidney Dis; 2012 Aug 30; 60(2):233-40. PubMed ID: 22542304 [Abstract] [Full Text] [Related]
39. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. Cummings JJ, Shaw AD, Shi J, Lopez MG, O'Neal JB, Billings FT. J Thorac Cardiovasc Surg; 2019 Apr 30; 157(4):1545-1553.e5. PubMed ID: 30389130 [Abstract] [Full Text] [Related]
40. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI. Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL. Clin Chim Acta; 2016 Jan 15; 452():32-7. PubMed ID: 26522657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]